We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

9104:TSEMitsui O.S.K.Lines,Ltd. Analysis

Data as of 2026-05-24 - not real-time

¥5,650.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Mitsui O.S.K. Lines is trading near its recent support level with the RSI indicating oversold conditions and a bearish MACD histogram, suggesting short‑term price pressure. Valuation metrics such as a price‑to‑earnings well below the industry average and a DCF fair value roughly 19% higher than the market price point to a significant upside potential, while the 3.6% dividend yield and modest payout ratio add income appeal.
However, the company operates in a highly cyclical marine shipping sector and faces geopolitical headwinds, exemplified by recent concerns over vessel transits through Hormuz. Its balance sheet shows elevated debt levels offset by a sizable cash pile, and a planned real‑estate investment trust could diversify earnings. Investors should weigh the strong dividend and valuation upside against sector volatility and debt exposure when deciding on positioning.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near technical support with oversold momentum
  • Geopolitical uncertainty around Middle East shipping lanes
  • Attractive dividend yield despite short‑term volatility

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Valuation gap of roughly 19% versus DCF fair value
  • Stable dividend and low market beta indicating defensive characteristics
  • Potential earnings recovery as global bulk and container demand improves

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Diversified business mix including shipping, logistics, and upcoming REIT
  • Strong cash reserves to service debt and support dividend sustainability
  • Long‑term upside from industry consolidation and green‑shipping initiatives

Key Metrics & Analysis

Financial Health

Revenue Growth5.00%
Profit Margin11.68%
P/E Ratio9.1
ROE7.57%
ROA1.41%
Debt/Equity84.67
P/B Ratio0.7
Op. Cash Flow¥451.0B
Free Cash Flow¥-337280860160
Industry P/E29.7

Technical Analysis

TrendNeutral
RSI33.5
Support¥5,589.00
Resistance¥6,187.00
MA 20¥5,882.30
MA 50¥6,243.08
MA 200¥5,134.73
MACDBearish
VolumeDecreasing
Fear & Greed Index91.61

Valuation

Fair Value¥8,209.42
Target Price¥6,725.45
Upside/Downside19.03%
GradeUndervalued
TypeValue
Dividend Yield3.63%

Risk Assessment

Beta0.05
Volatility27.31%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.